363 related articles for article (PubMed ID: 25456696)
21. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations.
Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788
[No Abstract] [Full Text] [Related]
22. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S;
JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807
[No Abstract] [Full Text] [Related]
23. Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography.
Seo J; Kim Y; Kim BK; Hong SJ; Ahn CM; Kim JS; Cho DK; Ko YG; Choi D; Hong MK; Jang Y
Cardiol J; 2020; 27(2):208-209. PubMed ID: 32463107
[No Abstract] [Full Text] [Related]
24. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
Pichette M; Chevalier F; Généreux P
Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
[TBL] [Abstract][Full Text] [Related]
25. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
Brown AJ; McCormick LM; Hoole SP; West NE
JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
[No Abstract] [Full Text] [Related]
26. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
Wiebe J; Hamm C; Nef H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
[TBL] [Abstract][Full Text] [Related]
27. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
[No Abstract] [Full Text] [Related]
28. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
29. Hybrid Strategy for Long Diffuse Coronary Lesion.
Basavarajaiah S; Qadir M
JACC Cardiovasc Interv; 2015 Sep; 8(11):1518-1521. PubMed ID: 26298227
[No Abstract] [Full Text] [Related]
30. Follow-up of coronary artery patency after implantation of bioresorbable coronary scaffolds: The emerging role of magnetic coronary artery imaging.
Zuin M; Rigatelli G; Scaranello F; Rinuncini M; Picariello C; D'Elia K; Fejzo M; Roncon L
Cardiovasc Revasc Med; 2017; 18(5):369-373. PubMed ID: 28254259
[TBL] [Abstract][Full Text] [Related]
31. Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
García-García HM; Schultz C; Duckers E; Regar E; Ligthart J; Serruys PW; van Geuns RJ
EuroIntervention; 2013 Feb; 8(10):1126-7. PubMed ID: 23014900
[No Abstract] [Full Text] [Related]
32. Hybrid percutaneous coronary revascularisation for a patient with left main bifurcation and extensive, diffuse coronary artery disease.
Panoulas VF; Miyazaki T; Sato K; Naganuma T; Latib A; Colombo A
Int J Cardiol; 2014 May; 173(2):e20-2. PubMed ID: 24679694
[No Abstract] [Full Text] [Related]
33. Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis.
Subban V; Sengottuvelu G; Uthayakumaran K; Rajendran R; Janakiraman E; Pakshirajan B; Thenpally JG; Kalidoss L; Victor SM; Kalarickal MS; Ajit MS
Int J Cardiol; 2016 Oct; 220():32-42. PubMed ID: 27372040
[TBL] [Abstract][Full Text] [Related]
34. Sealing of calcified plaques after bioresorbable scaffold implantations: a five-year follow up.
Tenekecioglu E; Bourantas CV; Onuma Y; Serruys PW
Int J Cardiovasc Imaging; 2017 Apr; 33(4):451-452. PubMed ID: 28004209
[No Abstract] [Full Text] [Related]
35. Bioresorbable vascular scaffold collapse causes subacute thrombosis.
Ruiz-Salmerón RJ; Pereira S; de Araujo D
J Invasive Cardiol; 2014 Jul; 26(7):E98-9. PubMed ID: 24993999
[TBL] [Abstract][Full Text] [Related]
36. Subacute recoil in bioresorbable vascular scaffold in a complex coronary lesion: A lesson from daily clinical practice.
Centola M; Lucreziotti S; Salerno-Uriarte D; Tresoldi S; Cannone G; Sponzilli C; Carugo S
Int J Cardiol; 2016 Jan; 203():995-6. PubMed ID: 26625328
[No Abstract] [Full Text] [Related]
37. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions.
Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A
Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860
[No Abstract] [Full Text] [Related]
38. Three-dimensional optical coherence tomography evaluation of a left main bifurcation lesion treated with ABSORB® bioresorbable vascular scaffold including fenestration and dilatation of the side branch.
Grundeken MJ; Kraak RP; de Bruin DM; Wykrzykowska JJ
Int J Cardiol; 2013 Oct; 168(3):e107-8. PubMed ID: 23972365
[No Abstract] [Full Text] [Related]
39. Bifurcation lesions: Bioresorbable vascular scaffold and drug coated balloon, an efficacy association. Lessons from optimal coherence tomography.
Piraino D; Carella M; Buccheri D; Andolina G
Int J Cardiol; 2016 Jun; 212():92-3. PubMed ID: 27038711
[No Abstract] [Full Text] [Related]
40. Optical coherence tomography follow-up after bioresorbable in metallic and metallic in bioresorbable stenting: tackling in-stent restenosis in the era of bioresorbable vascular scaffolds.
Frangieh AH; Templin C; Binder RK
Eur Heart J; 2015 Aug; 36(32):2183. PubMed ID: 26040803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
